Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data and Trends in Adverse Drug Reactions

Neuausgabe 2008
ISBN: 978-0-444-52767-7
Verlag: ELSEVIER SCIENCE PUB CO

Buch, Englisch, Band 30, 672 Seiten, Format (B × H): 156 mm x 234 mm, Gewicht: 1123 g

Reihe: Side Effects of Drugs Annual

The Side Effects of Drugs Annual was first published in 1977. It has been continually published since then, as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs. Each new Annual continues to provide clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of Adverse Drug Reactions and Interactions. An international team of specialists has contributed to the informative, by critically interpreting it, and by pointing to whatever is misleading.

Zielgruppe

Pharmacologists, clinicians, pharmaceutical companies, clinical toxicologists, clinical pharmacologists and medical libraries.

Autoren/Hrsg.

Aronson, Jeffrey K.

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Pharmazie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
• Technische Wissenschaften Verfahrenstechnik | Chemieingenieurwesen | Biotechnologie Pharmazeutische Technologie
• Naturwissenschaften Chemie Chemie Allgemein Pharmazeutische Chemie, Medizinische Chemie

Inhaltsverzeichnis

Contributors
Special Reviews
Cumulative Index of Special Reviews, Annuals 13 - 29
DoTS Classification of Adverse Drug Reactions
How to use this book
ESSAYS:

Central nervous system stimulants and drugs that suppress appetite
Antidepressant drugs

Lithium
Drugs of abuse
Hypnotics and sedatives
Antipsychotic drugs
Antiepileptic drugs
Opioid analgesics and narcotic antagonists
Anti-inflammatory and antipyretic analgesics and drugs used in gout
General anesthetics and therapeutic gases
Local anesthetics
Neuromuscular blocking agents and skeletal muscle relaxants
Drugs that affect autonomic functions or the extrapyramidal system
Dermatological drugs, topical agents and cosmetics
Antihistamines (H1 receptor antagonists)
Drugs acting on the respiratory tract

Positive inotropic drugs and drugs used in dysrhythmias
Beta-adrenoceptor antagonists and antianginal drugs

Drugs acting on the cerebral and peripheral circulations

Antihypertensive drugs

Diuretics

Metals

Metal antagonists

Antiseptic drugs and disinfectants

Penicillins, cephalosporins, other beta-lactam antibiotics, and tetracyclines
Miscellaneous antibacterial drugs
Antifungal drugs

Antiprozotoal Drugs

Antiviral drugs

Drugs used in tuberculosis and leprosy

Antihelminthic drugs

Vaccines

Blood, blood components, plasma and plasma products

Formulations used in nutrition
Drugs affecting blood coagulation, fibrinolysis, and hemostasis
Gastrointestinal drugs

Drugs that act on the immune system: cytokines and monoclonal antibodies

Drugs that act on the immune system: immunosuppressive and immunostimulatory drugs
Corticotrophins, corticosteroids, and prostaglandins
Sex hormones and related compounds, including hormonal contraceptives

Thyroid hormones, iodine, and antithyroid drugs

Insulin, other hypoglycemic drugs, and glucagon

Miscellaneous hormones

Drugs that affect lipid metabolism

Cytostatic drugs

Radiological contrast agents

Drugs used in ocular treatment

Treatments used in complementary and alternative medicine

Miscellaneous drugs and materials, medical devices and techniques

Über Autor(innen)

Aronson, Jeffrey K.
Dr Jeffrey K. Aronson is a consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford and a consultant physician in the Oxford Radcliffe Hospitals Trust. He has been associated with the Meyler series since 1977 and has published many research papers on adverse drug reactions. He is President of the British Pharmacological Society and serves on many committees concerned with drug therapy, including the Technology Appraisal Committee of the UK's National Institute for Health and Clinical Excellence (NICE) and the Joint Formulary Committees of the British National Formulary and the British National Formulary for Children.